NPS Pharmaceuticals (NPSP)

14.53 +0.42  +2.98%  May 21, 4:53PM
Add to Watchlists Create an Alert
View Full Chart
NPSP Price Chart
    View All Performance Charts

    NPSP Total Returns Comparison

    This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NPS Pharmaceuticals is up 103.8% over the last year vs S&P 500 Total Return up 31.95%, ACADIA Pharmaceuticals up 871.1%, and Vertex Pharmaceuticals up 29.52%.

    NPSP Fundamentals

    Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

    Income Statement View Statement

    Balance Sheet View Statement

    Total Assets 151.11M
    Liabilities 205.75M
    Get Quote for

    Pro Report PDF for NPSP

    Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

    Download NPSP Pro Report PDF

    Pro Strategies Featuring NPSP

    Did NPS Pharmaceuticals make it into our Pro Portfolio Strategies?

    Start your YCharts Pro membership now to find out.

    NPSP Profile

    Exchange: NASDAQ
    Sector: Healthcare
    Industry: Biotechnology

    NPS Pharmaceuticals, Inc. engages in the discovering, developing and commercializing small molecule drugs and recombinant proteins. Its existing product candidates are primarily for the treatment of bone and mineral, gastrointestinal and central nervous system disorders. The company is currently advancing two late-stage programs. Teduglutide, a proprietary analog of glucagon and preclinical development for additional intestinal failure related conditions. NPSP558 is a clinical development as a hormone therapy for hypoparathyroidism. Its product portfolio consists of a United States Food and Drug Administration approved product, as well as product candidates in various stages of clinical development and preclinical development. NPS Pharmaceuticals, Inc. was founded on October 22, 1986 and is based in Bedminster, New Jersey.

    Recent Quotes

    Symbol Price Chg Chg % Market Cap
    NPSP 14.53 +0.42 +2.98% 1.263B
    New watchlist
    Create
    Success.

    Your new watchlist has been created

    View WatchlistsDone
    Create Watchlist from Quotes

    Register for your Free YCharts Account.

    Understand your investments with more data than any other free site.

    • Create watchlists that you care about for stocks or economic indicators
    • Create alerts to track the movements of your stocks
    • Access stock analysis from our in-house experts
    Get Started Now

    Already registered? Sign in to your account.

    document.write('');